vs
Mission Produce, Inc.（AVO）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Mission Produce, Inc.的1.9倍（$622.0M vs $319.0M），Royalty Pharma plc净利率更高（34.4% vs 5.0%，领先29.4%），Royalty Pharma plc同比增速更快（4.8% vs -10.0%），过去两年Mission Produce, Inc.的营收复合增速更高（11.0% vs 4.6%）
根据现有信息，该描述将Mission Produce, Inc.错误混淆为一家日本电子游戏企业。原描述提及这家企业由前IREM员工于1990年4月6日创立，曾为艾尼克斯、哈德森开发多款游戏，作品覆盖街机、超级任天堂、Nintendo 64、PlayStation等多个平台。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
AVO vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$319.0M
营收增速更快
RPRX
高出14.8%
-10.0%
净利率更高
RPRX
高出29.4%
5.0%
两年增速更快
AVO
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $319.0M | $622.0M |
| 净利润 | $16.0M | $214.2M |
| 毛利率 | 17.5% | — |
| 营业利润率 | 8.8% | 62.4% |
| 净利率 | 5.0% | 34.4% |
| 营收同比 | -10.0% | 4.8% |
| 净利润同比 | -7.5% | 2.9% |
| 每股收益（稀释后） | $0.23 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVORPRX
| Q4 25 | $319.0M | $622.0M | ||
| Q3 25 | $357.7M | $609.3M | ||
| Q2 25 | $380.3M | $578.7M | ||
| Q1 25 | $334.2M | $568.2M | ||
| Q4 24 | $354.4M | $593.6M | ||
| Q3 24 | $324.0M | $564.7M | ||
| Q2 24 | $297.6M | $537.3M | ||
| Q1 24 | $258.7M | $568.0M |
净利润AVORPRX
| Q4 25 | $16.0M | $214.2M | ||
| Q3 25 | $14.7M | $288.2M | ||
| Q2 25 | $3.1M | $30.2M | ||
| Q1 25 | $3.9M | $238.3M | ||
| Q4 24 | $17.3M | $208.2M | ||
| Q3 24 | $12.4M | $544.0M | ||
| Q2 24 | $7.0M | $102.0M | ||
| Q1 24 | $0 | $4.8M |
毛利率AVORPRX
| Q4 25 | 17.5% | — | ||
| Q3 25 | 12.6% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 9.4% | — | ||
| Q4 24 | 15.7% | — | ||
| Q3 24 | 11.4% | — | ||
| Q2 24 | 10.4% | — | ||
| Q1 24 | 11.1% | — |
营业利润率AVORPRX
| Q4 25 | 8.8% | 62.4% | ||
| Q3 25 | 5.9% | 70.1% | ||
| Q2 25 | 1.8% | 36.3% | ||
| Q1 25 | 2.8% | 94.0% | ||
| Q4 24 | 8.1% | 60.9% | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 4.1% | 50.2% | ||
| Q1 24 | 3.1% | -13.0% |
净利率AVORPRX
| Q4 25 | 5.0% | 34.4% | ||
| Q3 25 | 4.1% | 47.3% | ||
| Q2 25 | 0.8% | 5.2% | ||
| Q1 25 | 1.2% | 41.9% | ||
| Q4 24 | 4.9% | 35.1% | ||
| Q3 24 | 3.8% | 96.3% | ||
| Q2 24 | 2.4% | 19.0% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）AVORPRX
| Q4 25 | $0.23 | $0.49 | ||
| Q3 25 | $0.21 | $0.67 | ||
| Q2 25 | $0.04 | $0.07 | ||
| Q1 25 | $0.05 | $0.55 | ||
| Q4 24 | $0.25 | $0.46 | ||
| Q3 24 | $0.17 | $1.21 | ||
| Q2 24 | $0.10 | $0.23 | ||
| Q1 24 | $0.00 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.8M | $618.7M |
| 总债务越低越好 | $95.8M | $9.0B |
| 股东权益账面价值 | $587.3M | $9.7B |
| 总资产 | $983.0M | $19.6B |
| 负债/权益比越低杠杆越低 | 0.16× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资AVORPRX
| Q4 25 | $64.8M | $618.7M | ||
| Q3 25 | $43.7M | $938.9M | ||
| Q2 25 | $36.7M | $631.9M | ||
| Q1 25 | $40.1M | $1.1B | ||
| Q4 24 | $58.0M | $929.0M | ||
| Q3 24 | $49.5M | $950.1M | ||
| Q2 24 | $46.2M | $1.8B | ||
| Q1 24 | $39.9M | $843.0M |
总债务AVORPRX
| Q4 25 | $95.8M | $9.0B | ||
| Q3 25 | $131.5M | $8.9B | ||
| Q2 25 | $147.2M | $8.0B | ||
| Q1 25 | $117.9M | $7.6B | ||
| Q4 24 | $113.7M | $7.6B | ||
| Q3 24 | $134.4M | $7.6B | ||
| Q2 24 | $170.2M | $7.6B | ||
| Q1 24 | $156.1M | $6.1B |
股东权益AVORPRX
| Q4 25 | $587.3M | $9.7B | ||
| Q3 25 | $568.7M | $9.6B | ||
| Q2 25 | $552.3M | $9.5B | ||
| Q1 25 | $550.8M | $9.8B | ||
| Q4 24 | $547.3M | $10.3B | ||
| Q3 24 | $527.3M | $10.3B | ||
| Q2 24 | $513.3M | $9.8B | ||
| Q1 24 | $505.1M | $9.9B |
总资产AVORPRX
| Q4 25 | $983.0M | $19.6B | ||
| Q3 25 | $1.0B | $19.3B | ||
| Q2 25 | $1.0B | $18.3B | ||
| Q1 25 | $997.8M | $17.6B | ||
| Q4 24 | $971.5M | $18.2B | ||
| Q3 24 | $959.9M | $18.0B | ||
| Q2 24 | $966.9M | $17.7B | ||
| Q1 24 | $937.5M | $16.1B |
负债/权益比AVORPRX
| Q4 25 | 0.16× | 0.92× | ||
| Q3 25 | 0.23× | 0.93× | ||
| Q2 25 | 0.27× | 0.84× | ||
| Q1 25 | 0.21× | 0.78× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | 0.25× | 0.74× | ||
| Q2 24 | 0.33× | 0.78× | ||
| Q1 24 | 0.31× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $55.6M | — |
| 自由现金流率自由现金流/营收 | 17.4% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | 4.20× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $37.2M | — |
8季度趋势，按日历期对齐
经营现金流AVORPRX
| Q4 25 | $67.2M | $827.1M | ||
| Q3 25 | $34.4M | $702.6M | ||
| Q2 25 | $-11.8M | $364.0M | ||
| Q1 25 | $-1.2M | $596.1M | ||
| Q4 24 | $38.0M | $742.5M | ||
| Q3 24 | $42.5M | $703.6M | ||
| Q2 24 | $3.4M | $658.2M | ||
| Q1 24 | $9.5M | $664.6M |
自由现金流AVORPRX
| Q4 25 | $55.6M | — | ||
| Q3 25 | $22.6M | — | ||
| Q2 25 | $-25.0M | — | ||
| Q1 25 | $-16.0M | — | ||
| Q4 24 | $31.1M | — | ||
| Q3 24 | $34.9M | — | ||
| Q2 24 | $-4.4M | — | ||
| Q1 24 | $-400.0K | — |
自由现金流率AVORPRX
| Q4 25 | 17.4% | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | -6.6% | — | ||
| Q1 25 | -4.8% | — | ||
| Q4 24 | 8.8% | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | -1.5% | — | ||
| Q1 24 | -0.2% | — |
资本支出强度AVORPRX
| Q4 25 | 3.6% | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 3.8% | — |
现金转化率AVORPRX
| Q4 25 | 4.20× | 3.86× | ||
| Q3 25 | 2.34× | 2.44× | ||
| Q2 25 | -3.81× | 12.06× | ||
| Q1 25 | -0.31× | 2.50× | ||
| Q4 24 | 2.20× | 3.57× | ||
| Q3 24 | 3.43× | 1.29× | ||
| Q2 24 | 0.49× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVO
| Avocado | $256.9M | 81% |
| Blueberry | $36.5M | 11% |
| Mango | $18.7M | 6% |
| Other | $6.9M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
